Search research articles
Contact Us
Filters
Showing results (71-80 of 108) with videos related to
Page
of 11
Sort By:
Journal of Gastroenterology and Hepatology
|
September 1, 1991
Intestinal lymphokine-activated killer cells in inflammatory bowel disease
P G Hogan, P R Gibson, A J Hapel, et al.
International Journal of Cancer
|
September 15, 1976
Inflammatory cells in solid murine neoplasms. I. Tumor disaggregation and identification of constituent inflammatory cells
S W Russell, W F Doe, R G Hoskins, et al.
European Journal of Biochemistry
|
August 1, 1986
Monoclonal antibodies inhibitory to human plasmin. Definitive demonstration of a role for plasmin in activating the proenzyme of urokinase-type plasminogen activator
P S Sim, D R Fayle, W F Doe, et al.
British Medical Journal
|
March 20, 1971
Jejunal pH and folic acid
W F Doe, A V Hoffbrand, P I Reed, et al.
International Journal of Cancer
|
October 15, 1988
Urokinase-type plasminogen activator in colorectal carcinomas and adenomatous polyps: quantitative expression of active and proenzyme
P S Sim, R W Stephens, D R Fayle, et al.
Gut
|
October 1, 1973
Proceedings: In vitro culture of human jejunal mucosa: enzyme changes in tissue and culture medium
J D Mitchell, J M Mitchell, W F Doe, et al.
Gut
|
August 1, 1988
Lysis of colonic epithelial cells by allogeneic mononuclear and lymphokine activated killer cells derived from peripheral blood and intestinal mucosa: evidence against a pathogenic role in inflammatory bowel disease
P R Gibson, E van de Pol, W Pullman, et al.
European Journal of Biochemistry
|
August 14, 1999
A region between -141 and -61 bp containing a proximal AP-1 is essential for constitutive expression of urokinase-type plasminogen activator receptor
J Dang, D Boyd, H Wang, et al.
Gut
|
April 1, 1988
Ulcerative colitis--a disease characterised by the abnormal colonic epithelial cell?
P R Gibson, E van de Pol, P J Barratt, et al.
Biochemical and Biophysical Research Communications
|
January 30, 1990
Plasminogen activator inhibitor 2 (PAI-2) is not inactivated by exposure to oxidants which can be released from activated neutrophils
M S Baker, S P Green, N Goss, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 108) with videos related to
Sort By:
Page
of 11
Journal of Gastroenterology and Hepatology
|
September 1, 1991
Intestinal lymphokine-activated killer cells in inflammatory bowel disease
P G Hogan, P R Gibson, A J Hapel, et al.
International Journal of Cancer
|
September 15, 1976
Inflammatory cells in solid murine neoplasms. I. Tumor disaggregation and identification of constituent inflammatory cells
S W Russell, W F Doe, R G Hoskins, et al.
European Journal of Biochemistry
|
August 1, 1986
Monoclonal antibodies inhibitory to human plasmin. Definitive demonstration of a role for plasmin in activating the proenzyme of urokinase-type plasminogen activator
P S Sim, D R Fayle, W F Doe, et al.
British Medical Journal
|
March 20, 1971
Jejunal pH and folic acid
W F Doe, A V Hoffbrand, P I Reed, et al.
International Journal of Cancer
|
October 15, 1988
Urokinase-type plasminogen activator in colorectal carcinomas and adenomatous polyps: quantitative expression of active and proenzyme
P S Sim, R W Stephens, D R Fayle, et al.
Gut
|
October 1, 1973
Proceedings: In vitro culture of human jejunal mucosa: enzyme changes in tissue and culture medium
J D Mitchell, J M Mitchell, W F Doe, et al.
Gut
|
August 1, 1988
Lysis of colonic epithelial cells by allogeneic mononuclear and lymphokine activated killer cells derived from peripheral blood and intestinal mucosa: evidence against a pathogenic role in inflammatory bowel disease
P R Gibson, E van de Pol, W Pullman, et al.
European Journal of Biochemistry
|
August 14, 1999
A region between -141 and -61 bp containing a proximal AP-1 is essential for constitutive expression of urokinase-type plasminogen activator receptor
J Dang, D Boyd, H Wang, et al.
Gut
|
April 1, 1988
Ulcerative colitis--a disease characterised by the abnormal colonic epithelial cell?
P R Gibson, E van de Pol, P J Barratt, et al.
Biochemical and Biophysical Research Communications
|
January 30, 1990
Plasminogen activator inhibitor 2 (PAI-2) is not inactivated by exposure to oxidants which can be released from activated neutrophils
M S Baker, S P Green, N Goss, et al.
Page
of 11